[1]
|
Beck, L.J., Bonegio, R.G., Lambeau, G., et al. (2009) M-Type Phospholipase A2 Receptor as Target Antigen in Idio-pathic Membranous Nephropathy. The New England Journal of Medicine, 361, 11-21.
https://doi.org/10.1056/NEJMoa0810457
|
[2]
|
van de Logt, A.E., Fresquet, M., Wetzels, J.F. and Brenchley, P. (2019) The Anti-PLA2R Antibody in Membranous Nephropathy: What We Know and What Remains a Decade after Its Discovery. Kidney International, 96, 1292-1302.
https://doi.org/10.1016/j.kint.2019.07.014
|
[3]
|
Provatopoulou, S., Kalavrizioti, D., Stangou, M., et al. (2019) Cir-culating Anti-Phospholipase A2 Receptor Antibodies as a Diagnostic and Prognostic Marker in Greek Patients with Idi-opathic Membranous Nephropathy—A Retrospective Cohort Study. Romanian Journal of Internal Medicine, 57, 141-150. https://doi.org/10.2478/rjim-2018-0044
|
[4]
|
Wu, W., Shang, J., Tao, C., et al. (2018) The Prognostic Value of Phospholipase A2 Receptor Autoantibodies on Spontaneous Remission for Patients with Idiopathic Membra-nous Nephropathy: A Meta-Analysis. Medicine, 97, e11018.
https://doi.org/10.1097/MD.0000000000011018
|
[5]
|
Liu, W., Gao, C., Dai, H., et al. (2019) Immunological Path-ogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role. Frontiers in Immunology, 10, Article 452994. https://doi.org/10.3389/fimmu.2019.01809
|
[6]
|
Lerner, G.B., Virmani, S., Henderson, J.M., Francis, J.M. and Beck Jr, L.H. (2021) A Conceptual Framework Linking Immunology, Pathology, and Clinical Features in Primary Membranous Nephropathy. Kidney International, 100, 289-300.
https://doi.org/10.1016/j.kint.2021.03.028
|
[7]
|
Qin, H.Z., Zhang, M.C., Le, W.B., et al. (2016) Combined As-sessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy. Journal of the American Society of Nephrology, 27, 3195-3203.
https://doi.org/10.1681/ASN.2015080953
|
[8]
|
Akiyama, S., Akiyama, M., Imai, E., et al. (2015) Prevalence of Anti-Phospholipase A2 Receptor Antibodies in Japanese Patients with Membranous Nephropathy. Clinical and Experi-mental Nephrology, 19, 653-660.
https://doi.org/10.1007/s10157-014-1054-2
|
[9]
|
Pourcine, F., Dahan, K., Mihout, F., et al. (2017) Prognostic Val-ue of PLA2R Autoimmunity Detected by Measurement of Anti-PLA2R Antibodies Combined with Detection of PLA2R Antigen in Membranous Nephropathy: A Single-Centre Study over 14 Years. PLOS ONE, 12, e0173201. https://pubmed.ncbi.nlm.nih.gov/28257452/
https://doi.org/10.1371/journal.pone.0173201
|
[10]
|
Li, W., Zhao, Y. and Fu, P. (2018) Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephrop-athy: An Updated Meta-Analysis. Frontiers in Medicine, 5, 362942. https://doi.org/10.3389/fmed.2018.00101
|
[11]
|
刘中宪. 抗PLA2R抗体在特发性膜性肾病诊治中的意义及与病情的相关性[J]. 辽宁医学杂志, 2023, 37(2): 67-70.
|
[12]
|
Gunnarsson, I., Schlumberger, W. and Ronnelid, J. (2012) Antibodies to M-Type Phospholipase A2 Re-ceptor (PLA2R) and Membranous Lupus Nephritis. American Journal of Kidney Diseases, 59, 585-586.
https://doi.org/10.1053/j.ajkd.2011.10.044
|
[13]
|
Qin, W., Beck Jr, L.H., Zeng, C., et al. (2011) Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy. Journal of the American Society of Nephrology, 22, 1137-1143. https://doi.org/10.1681/ASN.2010090967
|
[14]
|
Svobodova, B., Honsova, E., Ronco, P., Tesar, V. and Debiec, H. (2013) Kidney Biopsy Is a Sensitive Tool Forretrospective Diagnosis of PLA2R-Related Membranous Nephropathy. Nephrology Dialysis Transplantation, 28, 1839-1844.
https://doi.org/10.1093/ndt/gfs439
|
[15]
|
许秀华, 许树根, 梁萌, 等. 肾小球PLA2R检测在膜性肾病诊断中的应用[J]. 东南国防医药, 2017, 19(3): 254-257.
|
[16]
|
Larsen, C.P., Messias, N.C., Silva, F.G., Messias, E. and Walker, P.D. (2013) Determination of Primary versus Secondary Membranous Glomerulopathy Utilizing Phospholipase A2 Re-ceptor Staining in Renal Biopsies. Modern Pathology, 26, 709-715. https://doi.org/10.1038/modpathol.2012.207
|
[17]
|
Sethi, S., Debiec, H., Madden, B., et al. (2020) Neural Epidermal Growth Factor-Like 1 Protein (NELL-1) Associated Membranous Nephropathy. Kidney International, 97, 163-174. https://doi.org/10.1016/j.kint.2019.09.014
|
[18]
|
Garcia-Vives, E., Soléc, C., Moliné, T., et al. (2019) Antibodies to M-Type Phospholipase A2 Receptor (PLA2R) in Membranous Lupus Nephritis. Lupus, 28, 396-405. https://doi.org/10.1177/0961203319828521
|
[19]
|
Bobart, S.A., Vriese, A.D., Pawar, A.S., et al. (2019) Noninva-sive Diagnosis of Primary Membranous Nephropathy Using Phospholipase A2 Receptor Antibodies. Kidney Interna-tional, 95, 429-438.
https://doi.org/10.1016/j.kint.2018.10.021
|
[20]
|
蒋真斌, 蔡美顺, 董葆, 等. 适合中国人的抗磷脂酶A2受体抗体临界值的界定[J]. 中华肾脏病杂志, 2020, 36(5): 379-384.
|
[21]
|
王蒙, 王力宁, 刘楠, 等. 血清抗PLA2R抗体水平对特发性膜性肾病的诊断及预后评估[J]. 中国实用内科杂志, 2020, 40(2): 153-157.
|
[22]
|
Francis, J.M., Beck, L.J. and Salant, D.J. (2016) Membranous Nephropathy: A Journey from Bench to Bedside. American Journal of Kidney Diseases, 68, 138-147. https://doi.org/10.1053/j.ajkd.2016.01.030
|
[23]
|
李正东, 张任. 血清学PLA2R抗体和THSD7A抗体检测辅助诊断特发性膜性肾病及对评估疗效和预后的价值研究[J]. 中国煤炭工业医学杂志, 2019, 22(2): 149-157.
|
[24]
|
纪春阳, 边学燕, 包斯增. 血清PLA2R抗体、肾小球PLA2R及IgG4检测在膜性肾病诊断中的作用[J]. 中国卫生检验杂志, 2018, 28(17): 2138-2140.
|
[25]
|
潘艳, 刘磊, 常保超, 等. 血清PLA2R抗体为导向的膜性肾病的病情及预后评估[J]. 河南大学学报(医学版), 2020, 39(2): 119-121. https://doi.org/10.15991/j.cnki.41-1361/r.2020.02.012
|
[26]
|
Ruggenenti, P., Debiec, H., Ruggiero, B., et al. (2015) Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy. Jour-nal of the American Society of Nephrology, 26, 2545-2558.
https://doi.org/10.1681/ASN.2014070640
|
[27]
|
左科. 雷公藤治疗膜性肾病的随机对照试验及PLA2R抗体在治疗中的意义研究[D]: [博士学位论文]. 南京: 南京大学, 2016.
|
[28]
|
李超凡. 特发性膜性肾病的抗PLA2R抗体诊断与预后及MN合并抗GBM病的特点分析[D]: [硕士学位论文]. 济南: 山东大学, 2023. https://doi.org/10.27272/d.cnki.gshdu.2022.002223
|
[29]
|
Xiao, C., Liu, Y., Zhang, X., et al. (2020) Phospho-lipase-A2 Receptor Antibody, 24 Hours Proteinuria, and Serum Albumin as Indicators of Cyclophosphamide Efficacy in Idiopathic Membranous Nephropathy. Journal of Clinical Laboratory Analysis, 34, e23368. https://pubmed.ncbi.nlm.nih.gov/32449206/
https://doi.org/10.1002/jcla.23368
|
[30]
|
吴勉华, 石岩. 中医内科学[M]. 北京: 中国中医药出版社, 2021: 260-281.
|